UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Everest Group
EG
$14.2B
| $47.6M | 0.05% |
279,286
+5,266
| +2% | +$889K |
|
|
VAR
427
DELISTED
Varian Medical Systems, Inc.
VAR
| $47.5M | 0.05% |
626,582
+51,665
| +9% | +$3.84M |
|
428
Expedia Group
EXPE
$37.1B
| $47.4M | 0.05% |
555,682
+184,301
| +50% | +$15.6M |
|
|
ANDV
429
DELISTED
Andeavor
ANDV
| $47.2M | 0.05% |
635,446
+184,248
| +41% | +$13M |
|
430
Ball Corp
BALL
$16.8B
| $47.1M | 0.04% |
1,382,928
-20,996
| -1% | -$692K |
|
|
CTRA
431
DELISTED
Coterra Energy
CTRA
| $47.1M | 0.04% |
1,590,627
+56,238
| +4% | +$1.77M |
|
|
JWN
432
DELISTED
Nordstrom
JWN
| $46.8M | 0.04% |
589,250
-5,352
| -0.9% | -$393K |
|
433
Ionis Pharmaceuticals
IONS
$9.15B
| $46.4M | 0.04% |
750,897
-40,800
| -5% | -$2.01M |
|
|
XL
434
DELISTED
XL Group Ltd.
XL
| $46.2M | 0.04% |
1,344,334
+56,446
| +4% | +$1.92M |
|
435
Agilent Technologies
A
$39.2B
| $45.9M | 0.04% |
1,122,222
-475,011
| -30% | -$19.2M |
|
436
Realty Income
O
$58.7B
| $45.5M | 0.04% |
984,282
+21,132
| +2% | +$936K |
|
437
Teradata
TDC
$3.23B
| $45.4M | 0.04% |
1,039,067
+201,899
| +24% | +$8.65M |
|
438
CMS Energy
CMS
$22.5B
| $45M | 0.04% |
1,295,919
+2,714
| +0.2% | +$88.7K |
|
439
Dover
DOV
$28.2B
| $45M | 0.04% |
776,316
+12,862
| +2% | +$797K |
|
440
NVIDIA
NVDA
$5.12T
| $44.9M | 0.04% |
89,477,680
-2,366,880
| -3% | -$1.15M |
|
441
Fluor
FLR
$7.19B
| $44.7M | 0.04% |
737,262
+49,057
| +7% | +$3.1M |
|
|
CMA
442
DELISTED
Comerica
CMA
| $44.3M | 0.04% |
946,335
-2,718
| -0.3% | -$128K |
|
443
Expeditors International
EXPD
$23.4B
| $44M | 0.04% |
985,852
+38,610
| +4% | +$1.66M |
|
|
JOY
444
DELISTED
Joy Global Inc
JOY
| $43.9M | 0.04% |
944,180
+601,719
| +176% | +$30.8M |
|
|
TIF
445
DELISTED
Tiffany & Co.
TIF
| $43.6M | 0.04% |
408,439
+1,462
| +0.4% | +$146K |
|
446
Workday
WDAY
$41.6B
| $43.6M | 0.04% |
533,799
+285,387
| +115% | +$24.6M |
|
447
Polaris
PII
$4.2B
| $43.6M | 0.04% |
288,022
+13,743
| +5% | +$2.06M |
|
448
Fastenal
FAST
$56.7B
| $43.5M | 0.04% |
3,662,356
+9,040
| +0.2% | +$101K |
|
|
KSU
449
DELISTED
Kansas City Southern
KSU
| $43.4M | 0.04% |
355,341
+510
| +0.1% | +$61K |
|
450
J.M. Smucker
SJM
$12.7B
| $43.3M | 0.04% |
429,209
-1,333
| -0.3% | -$135K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.